Lyndsay Harris

Association between response to brief trastuzumab exposure in cell lines and early stage HER2+ breast tumors

David Tuck, Steven H. Kleinstein, Emmett Sprecher, 2011, BCB '11.

Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.

Lyndsay Harris, Donald Berry, Larry Norton, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Liposome‐encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first‐line therapy of metastatic breast carcinoma

Lyndsay Harris, Gerald Batist, E. Winer, 2002, Cancer.